Detailed TOC of Global Obesity Treatment Market Research Report 2024
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Obesity Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Surgical & Implant Devices
1.2.3 Medication Therapy
1.2.4 Dietary
1.2.5 Other
1.3 Market by Application
1.3.1 Global Obesity Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Children
1.3.3 Adults
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Obesity Treatment Market Perspective (2018-2029)
2.2 Obesity Treatment Growth Trends by Region
2.2.1 Global Obesity Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Obesity Treatment Historic Market Size by Region (2018-2024)
2.2.3 Obesity Treatment Forecasted Market Size by Region (2024-2029)
2.3 Obesity Treatment Market Dynamics
2.3.1 Obesity Treatment Industry Trends
2.3.2 Obesity Treatment Market Drivers
2.3.3 Obesity Treatment Market Challenges
2.3.4 Obesity Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Obesity Treatment Players by Revenue
3.1.1 Global Top Obesity Treatment Players by Revenue (2018-2024)
3.1.2 Global Obesity Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Obesity Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Obesity Treatment Revenue
3.4 Global Obesity Treatment Market Concentration Ratio
3.4.1 Global Obesity Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Obesity Treatment Revenue in 2022
3.5 Obesity Treatment Key Players Head office and Area Served
3.6 Key Players Obesity Treatment Product Solution and Service
3.7 Date of Enter into Obesity Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Obesity Treatment Breakdown Data by Type
4.1 Global Obesity Treatment Historic Market Size by Type (2018-2024)
4.2 Global Obesity Treatment Forecasted Market Size by Type (2024-2029)
5 Obesity Treatment Breakdown Data by Application
5.1 Global Obesity Treatment Historic Market Size by Application (2018-2024)
5.2 Global Obesity Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Obesity Treatment Market Size (2018-2029)
6.2 North America Obesity Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Obesity Treatment Market Size by Country (2018-2024)
6.4 North America Obesity Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Obesity Treatment Market Size (2018-2029)
7.2 Europe Obesity Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Obesity Treatment Market Size by Country (2018-2024)
7.4 Europe Obesity Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Obesity Treatment Market Size (2018-2029)
8.2 Asia-Pacific Obesity Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Obesity Treatment Market Size by Region (2018-2024)
8.4 Asia-Pacific Obesity Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Obesity Treatment Market Size (2018-2029)
9.2 Latin America Obesity Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Obesity Treatment Market Size by Country (2018-2024)
9.4 Latin America Obesity Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Obesity Treatment Market Size (2018-2029)
10.2 Middle East & Africa Obesity Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Obesity Treatment Market Size by Country (2018-2024)
10.4 Middle East & Africa Obesity Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NutriSystem, Inc. (U.S.)
11.1.1 NutriSystem, Inc. (U.S.) Company Detail
11.1.2 NutriSystem, Inc. (U.S.) Business Overview
11.1.3 NutriSystem, Inc. (U.S.) Obesity Treatment Introduction
11.1.4 NutriSystem, Inc. (U.S.) Revenue in Obesity Treatment Business (2018-2024)
11.1.5 NutriSystem, Inc. (U.S.) Recent Development
11.2 Kellogg Company (U.S.)
11.2.1 Kellogg Company (U.S.) Company Detail
11.2.2 Kellogg Company (U.S.) Business Overview
11.2.3 Kellogg Company (U.S.) Obesity Treatment Introduction
11.2.4 Kellogg Company (U.S.) Revenue in Obesity Treatment Business (2018-2024)
11.2.5 Kellogg Company (U.S.) Recent Development
11.3 Ethicon, Inc. (U.S.)
11.3.1 Ethicon, Inc. (U.S.) Company Detail
11.3.2 Ethicon, Inc. (U.S.) Business Overview
11.3.3 Ethicon, Inc. (U.S.) Obesity Treatment Introduction
11.3.4 Ethicon, Inc. (U.S.) Revenue in Obesity Treatment Business (2018-2024)
11.3.5 Ethicon, Inc. (U.S.) Recent Development
11.4 Medtronic (U.S.)
11.4.1 Medtronic (U.S.) Company Detail
11.4.2 Medtronic (U.S.) Business Overview
11.4.3 Medtronic (U.S.) Obesity Treatment Introduction
11.4.4 Medtronic (U.S.) Revenue in Obesity Treatment Business (2018-2024)
11.4.5 Medtronic (U.S.) Recent Development
11.5 F. Hoffmann-La Roche (Switzerland)
11.5.1 F. Hoffmann-La Roche (Switzerland) Company Detail
11.5.2 F. Hoffmann-La Roche (Switzerland) Business Overview
11.5.3 F. Hoffmann-La Roche (Switzerland) Obesity Treatment Introduction
11.5.4 F. Hoffmann-La Roche (Switzerland) Revenue in Obesity Treatment Business (2018-2024)
11.5.5 F. Hoffmann-La Roche (Switzerland) Recent Development
11.6 Atkins Nutritionals, Inc. (U.S.)
11.6.1 Atkins Nutritionals, Inc. (U.S.) Company Detail
11.6.2 Atkins Nutritionals, Inc. (U.S.) Business Overview
11.6.3 Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Introduction
11.6.4 Atkins Nutritionals, Inc. (U.S.) Revenue in Obesity Treatment Business (2018-2024)
11.6.5 Atkins Nutritionals, Inc. (U.S.) Recent Development
11.7 Herbalife Ltd. (U.S.)
11.7.1 Herbalife Ltd. (U.S.) Company Detail
11.7.2 Herbalife Ltd. (U.S.) Business Overview
11.7.3 Herbalife Ltd. (U.S.) Obesity Treatment Introduction
11.7.4 Herbalife Ltd. (U.S.) Revenue in Obesity Treatment Business (2018-2024)
11.7.5 Herbalife Ltd. (U.S.) Recent Development
11.8 Covidien plc (U.S.)
11.8.1 Covidien plc (U.S.) Company Detail
11.8.2 Covidien plc (U.S.) Business Overview
11.8.3 Covidien plc (U.S.) Obesity Treatment Introduction
11.8.4 Covidien plc (U.S.) Revenue in Obesity Treatment Business (2018-2024)
11.8.5 Covidien plc (U.S.) Recent Development
11.9 Apollo Endosurgery (U.S.)
11.9.1 Apollo Endosurgery (U.S.) Company Detail
11.9.2 Apollo Endosurgery (U.S.) Business Overview
11.9.3 Apollo Endosurgery (U.S.) Obesity Treatment Introduction
11.9.4 Apollo Endosurgery (U.S.) Revenue in Obesity Treatment Business (2018-2024)
11.9.5 Apollo Endosurgery (U.S.) Recent Development
11.10 Amer Sports (Finland)
11.10.1 Amer Sports (Finland) Company Detail
11.10.2 Amer Sports (Finland) Business Overview
11.10.3 Amer Sports (Finland) Obesity Treatment Introduction
11.10.4 Amer Sports (Finland) Revenue in Obesity Treatment Business (2018-2024)
11.10.5 Amer Sports (Finland) Recent Development
11.11 Johnson Health Technology, Ltd. (Taiwan)
11.11.1 Johnson Health Technology, Ltd. (Taiwan) Company Detail
11.11.2 Johnson Health Technology, Ltd. (Taiwan) Business Overview
11.11.3 Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Introduction
11.11.4 Johnson Health Technology, Ltd. (Taiwan) Revenue in Obesity Treatment Business (2018-2024)
11.11.5 Johnson Health Technology, Ltd. (Taiwan) Recent Development
11.12 Cybex International (U.S.)
11.12.1 Cybex International (U.S.) Company Detail
11.12.2 Cybex International (U.S.) Business Overview
11.12.3 Cybex International (U.S.) Obesity Treatment Introduction
11.12.4 Cybex International (U.S.) Revenue in Obesity Treatment Business (2018-2024)
11.12.5 Cybex International (U.S.) Recent Development
11.13 USGI Medical (U.S.)
11.13.1 USGI Medical (U.S.) Company Detail
11.13.2 USGI Medical (U.S.) Business Overview
11.13.3 USGI Medical (U.S.) Obesity Treatment Introduction
11.13.4 USGI Medical (U.S.) Revenue in Obesity Treatment Business (2018-2024)
11.13.5 USGI Medical (U.S.) Recent Development
11.14 Olympus Corporation (Japan)
11.14.1 Olympus Corporation (Japan) Company Detail
11.14.2 Olympus Corporation (Japan) Business Overview
11.14.3 Olympus Corporation (Japan) Obesity Treatment Introduction
11.14.4 Olympus Corporation (Japan) Revenue in Obesity Treatment Business (2018-2024)
11.14.5 Olympus Corporation (Japan) Recent Development
11.15 Brunswick Corporation (U.S.)
11.15.1 Brunswick Corporation (U.S.) Company Detail
11.15.2 Brunswick Corporation (U.S.) Business Overview
11.15.3 Brunswick Corporation (U.S.) Obesity Treatment Introduction
11.15.4 Brunswick Corporation (U.S.) Revenue in Obesity Treatment Business (2018-2024)
11.15.5 Brunswick Corporation (U.S.) Recent Development
11.16 Technogym SpA (Italy)
11.16.1 Technogym SpA (Italy) Company Detail
11.16.2 Technogym SpA (Italy) Business Overview
11.16.3 Technogym SpA (Italy) Obesity Treatment Introduction
11.16.4 Technogym SpA (Italy) Revenue in Obesity Treatment Business (2018-2024)
11.16.5 Technogym SpA (Italy) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
